MEMORANDUM AND ORDER
Plaintiff Dean Nicosia brings this putative class action against Amazon.com, Inc. (“Amazon” or “Amazon.com”), contending that Amazon has sold and continues to sell weight loss supplements containing sibu-tramine, a “controlled substance ... [that has] never been permitted for sale without a prescription from a licensed physician ... [and that is] associated with a serious risk of Cardiovascular events and strokes,” in violation of various federal and state consumer protection laws and in breach of various implied warranties. (Compl. ¶¶ 2, 86-175.) Currently before the Court are (1) Amazon’s motion to dismiss on the grounds that, inter alia, all of Plaintiffs claims are governed by a mandatory arbitration clause and class action waiver, and (2) Nicosia’s motion for a preliminary injunction, in which Nicosia asks this Court to grant the following injunctive relief:
A. Requiring Amazon to comply with the ‘special packaging’ rules promulgated by the Consumer Product Safety Commission;
B. Preliminarily enjoining Amazon from further distributing any weight loss products that contain sibutramine; and
C. Providing a court-approved remedial notice to all consumers to whom Amazon sold products containing sibu-tramine, and post the same notice conspicuously on its website.
(PI. PI Br. at 23-24.) Amazon’s motion to dismiss is granted because all of Plaintiffs claims are subject to mandatory arbitration and Plaintiffs motion for a prelimi
Factual Background
Plaintiff Dean Nicosia is a resident of Wilmington, North Carolina. He alleges that “during the class period(s) [he] was a resident of Massapequa, New York.” (Compl. ¶ 15.) Plaintiff twice, first on January 30, 2013 and then again on April 19, 2013, purchased diet drugs known as “1 Day Diet” from a third-party seller on. Amazon.com.- (Compl. ¶¶ 7, 54-55.)
Sibutramine is a controlled substance only available by prescription. The United States Food and Drug Administration (“FDA”) had previously published a press release, on October 8, 2010, stating the “continued availability” of a certain diet drug containing sibutramine “is not justified when you compare the very modest weight loss that people achieve on this drug to their risk of heart attack or stroke,” and reporting that the results of a clinical trial “demonstrated a 16 percent increase in the risk of serious heart events, including non-fatal heart attack, non-fatal stroke, the need to be resuscitated once the heart stopped, and death, in a group of patients given sibutramine compared to another given placebo.” (Compl. at ¶¶ 19-20 (quoting FDA Oct. 8, 2010 Press Release)).
Several months after Plaintiff made his purchases, on November 21, 2013, the FDA issued a “Public Notification” that the 1 Day Diet product contained “hidden” sibutramine. (Compl. ¶¶ 58-59.) The FDA’s November 21, 2013 Public Notification, which is directed towards the public, not retailers, does not call for any further action by retailers. It states that:
The Food and Drug Administration (FDA) is advising consumers not to purchase or use “1 Day Diet,” a product promoted and for weight loss on various websites and possibly in some retail stores.
FDA laboratory analysis confirmed that “1 Day Diet” contains sibutramine.... Consumers should stop using this product immediately and throw it away. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible....
Note: This notification is to inform the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building, and are often represented as being “all natural.” ■ FDA is unable to test and identify all products marketed as dietary supplements on the market that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories.
(Compl. at ¶ 19.)
The label on the container of the 1 Day Diet product did not list sibutramine as an ingredient. (Compl. at ¶ 7.) It is undisputed that neither Plaintiff nor Amazon knew, at the time that Plaintiff made his purchases, that the 1 Day Diet product contained sibutramine.
According to Plaintiff, in making his purchases, he used an online account that he established with Amazon.com on or about June 9, 2008. When setting up ,his account, Plaintiff checked a box indicating that he agreed with Amazon’s “Conditions of Use.” The Conditions of Use in effect in June 2008 (the “2008 Conditions of Use”) provided, in relevant part, that:
Any dispute relating in any way to your visit to Amazon.com or to products or services sold or distributed on Amazon or through Amazon.com in which theaggregate total claim for relief sought on behalf of one more parties exceeds $7,500 shall be adjudicated in any state or federal court in King County, Washington, and you consent to exclusive jurisdiction and venue in such courts.
(Duncan Decl. in Support of Pl.’s Opp’n to Motion to Dismiss Decl., Ex. C at 7.) The 2008 Conditions of Use also stated, in relevant part: “We reserve the right to make changes to our site, policies, and these Conditions of Use at any time.” (Id. at 8.)
In addition, both times that Plaintiff made the purchases at issue in this litigation on the Amazon.com website, he viewed a checkout screen that provided, on top, a hyperlink to the then-current Conditions of Use and reminded customers that “by placing [an] order,” they “agree to Amazon.eom’s conditions of use.” The Conditions of Use in effect as of December 5, 2012 through the period that Plaintiff made both of the purchases as issue in this litigation, (the “2012 Conditions of Use”), include the following provision, which is conspicuously displayed in bold font:
DISPUTES
Any dispute or claim relating in any way to your use of any Amazon Service, or to any products or services sold or distributed by Amazon or through Amazon.com will be resolved by binding arbitration, rather than in court, except that you may assert claims in small claims court if your claims qualify. The Federal Arbitration Act and federal arbitration law apply to this agreement.
There is no judge or jury in arbitration, and court review of an arbitration award is limited. However an arbitrator can award on an individual basis the same damages and relief as court (including injunctive, and declaratory relief or statutory damages), and must follow the terms of these Conditions of Use as a court would.
(Def. Ex. A at 5-6) (emphasis in original). The 2012 Conditions of Use also include a conspicuous class action waiver, also bold-ed, which states:
We each agree that any dispute resolution proceedings will be conducted only on an individual basis and not in class, consolidated or representative action.
(Id. at 6) (emphasis in original).
On November 21, 2013, the same day that the FDA.issued the Public Notifica
On July 28, 2014, Plaintiff commenced the instant putative class action against Amazon, contending that Amazon has sold and continues to sell many different weight loss supplements containing sibutramine in violation of various federal and state consumer protection laws and in breach of various implied warranties. (Compl. ¶¶ 2, 86-175.) Currently before the Court are two motions. First, Amazon’s motion to dismiss brought pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure on the grounds that, inter alia, Plaintiffs claims fall squarely within the scope of Amazon’s mandatory arbitration and class waiver clauses. Second, Plaintiffs motion for a preliminary injunction, seeking, inter alia, warnings be sent to all Amazon customers who purchased any product containing sibutramine.
Discussion
1. Motion to Dismiss
A. Legal Standard
Amazon’s motion is styled as a motion to dismiss “in favor of individual arbitration” pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure. (Def.’s Br. at 5.) “[A] number of other courts [in this Circuit] have ... construe[d] ... motion[s] to dismiss [based on the existence of mandatory arbitration clauses] as [ ] motionfs] to compel arbitration.” Jillian Mech. Corp. v. United Serv. Workers Union Local 355,
Under the now well-established Twom-bly standard applicable to motions to dismiss under Federal Rule of Civil Procedure 12(b)(6), a complaint should be dismissed only if it does not contain enough allegations of fact to state a claim for relief that is “plausible on its face.” Bell Atl. Corp. v. Twombly,
The Supreme Court has clarified that Twombly sets out a two-pronged approach for district courts considering motions to dismiss under Rule 12(b)(6). Iqbal,
The Court is generally limited to the “facts stated in the complaint or documents attached to the complaint as exhibits or incorporated by reference.” Nechis v. Oxford Health Plans, Inc.,
Here, Amazon has submitted a copy of the final purchase screen Plaintiff viewed prior to making his purchases, as well as the 2012 Conditions of Use which were hyperlinked on that page. In his complaint, Plaintiff clearly states that on two specific dates, in February and again in April 2013, he made purchases on Ama-zomcom’s website using his credit card, for which he was charged and not refunded $37.83 and $20.66, respectively. (Compl. ¶¶ 15, 54-55, 75-76.) He states that the website did not disclose that 1 Day Diet contained sibutramine. (Compl. ¶¶ 52-53.) Plaintiff does not dispute that documents submitted by Amazon are the Conditions
B. Choice of Law
The Federal Arbitration Act (the “FAA”) creates a “body of federal substantive law of arbitrability” applicable to arbitration agreements. Alliance Bernstein Inv. Research & Mgmt., Inc. v. Schaffran,
C. Are Plaintiff’s Claims Subject to Mandatory Arbitration on an Individual Basis?
In enacting the FAA, Congress intended to “counteract an historic judicial
Here, Amazon attempts to enforce the mandatory arbitration provision and class action waiver contained in its 2012 Conditions of Use, which was in effect at the time that Plaintiff made the purchases at issue in this litigation. Plaintiff does not dispute that the 2012 Conditions of Use contain a mandatory arbitration provision and class action waiver, but asserts that the terms of 2012 Conditions of Use are not enforceable against him because he did not manifest his intent to be bound by those terms. Amazon asserts that a valid contract was formed when Plaintiff, prior to executing his purchases, viewed a final checkout screen which stated, as the first line of text under a bold “Review your order” caption, that: “By placing your order, you agree to Amazomcom’s privacy notice and conditions of use.” The words “conditions of use” were displayed in blue font and hyperlinked to the Conditions of Use that were in effect at the time of the purchases. To place his orders, Plaintiff had to navigate past this screen by clicking a square icon below and to the right of this disclaimer, which states: “Place your order.” Thus, the question is whether displaying a blue hyperlink to the current Conditions of Use on the top of the final checkout page, along with a conspicuous warning that: “By placing your order, you agree to Amazomcom’s ... conditions of use,” is sufficient to incorporate the terms of the Conditions of Use into the purchase agreement. This Court holds that, for the following reasons, it is.
The parties agree that the question of whether they have contractually bound themselves to arbitrate is governed by Washington state law. “It is a basic tenet of [Washington] contract law ... that in order to be binding, a contract requires a
In Kwan, the only relevant case applying Washington law of which this Court is aware, the District Court for the Western District of Washington relied heavily on the Second Circuit Court of Appeals’ “seminal decision” in Specht v. Netscape Comm’ns Corp., in finding that a website user did not assent to be bound to the defendant’s terms of use, which included a mandatory arbitration clause, because, inter alia, the terms of use were buried two or three clicks into the defendant’s website. Kwan,
Here, Amazon’s 2012 Conditions of Use agreement is a hybrid between a clickwrap and a browsewrap agreement. While the Conditions of Use are only available by navigating through a hyperlink, like a browsewrap agreement, a purchaser using Amazon’s website could only place his or her order after viewing a conspicuous hyperlink to the current Conditions of Use and agreeing to make his purchase subject to those conditions. Additionally, a purchaser cannot make purchases on Amazon.com without first signing-up for an
Upon review of Amazon’s initial sign-up page and final checkout page, this Court finds that Plaintiff was, at a minimum, on inquiry notice of the current terms of the Conditions of Use when making his purchases. First, he expressly agreed, when he signed up for an account with Amazon.com, to be bound by the terms of the Conditions of Use, and indicated that, inter alia, he understood that the terms of the Conditions of Use were subject to change. Second, he was put on inquiry notice of the current terms each time he made a purchase, as a conspicuous hyperlink to the current Conditions of Use was “presented to and agreed to by ... Plaintiff], each and every time [he] made a purchase.” Ekin v. Amazon Services, LLC,
D. Are Plaintiff’s Challenges to the Enforceability of the Conditions of Use Subject to Mandatory Arbitration on an Individual Basis?
Plaintiff argues that he cannot be bound to the terms of the Conditions of Use for two additional reasons. First, he argues that the 2012 Conditions of Use lack mutuality and are illusory because Amazon reserved the right to change its terms at any time. Second, he argues that any contract relating to the sale of the 1 Day Diet product is void as an illegal contract because Amazon could not lawfully sell any product containing sibutramine without a prescription.
Challenges to the validity of arbitration agreements can be divided into two types: Those that “challenge! ] specifically the validity of the agreement to arbitrate” and those that “challenge! ] the contract as a whole, either on a ground that directly affects the entire agreement (e.g., the agreement was fraudulently induced), or on the ground that the illegality of one of the contract’s provisions renders the whole contract invalid.” Buckeye,
“Plaintiffs’ argument that the contract is illusory, and thus the arbitration clause non-binding, is not a matter for this Court to decide.” Gilroy v. Seabourn Cruise Line, Ltd., No. C12-107Z,
II. Plaintiff’s Motion for a Preliminary Injunction
In a separate motion, Plaintiff asks this Court to grant the following injunctive relief prior to sending the case the arbitration:
A. Requiring Amazon to comply with the ‘special packaging’ rules promulgated by the Consumer Product Safety Commission;
B. Preliminarily enjoining Amazon from further distributing any weight loss products that contain sibutramine; and
C. Providing a court-approved remedial notice to all consumers to whom Amazon sold products containing sibu-tramine, and post the same notice conspicuously on its website.
(Pl. Br. at 23-24.) Plaintiff asserts that he is entitled to such relief under traditional standards for preliminary injunctive relief and under standards applicable to injunctions under the Consumer Product Safety Act, (the “CPSA”), 15 U.S.C.A. § 2051 et seq.
A. This Court May Grant a Preliminary Injunction in a Case Bound for Arbitration
It is well-settled in this Circuit that district courts generally “should consider the merits of a requested preliminary injunction even where the validity of the underlying claims will be determined in arbitration.” Am. Exp. Fin. Advisors Inc. v. Thorley,
Here, Plaintiffs requested injunctive relief aims to change, rather than preserve, the status quo during the pendency of the arbitration. In its opposition, Amazon argues that this Court is not empowered to grant a so-called mandatory preliminary injunction in aid of arbitration, but rather, is only empowered to preserve the status quo in order to protect the anticipated arbitration from becoming a “hollow formality.” Blumenthal,
B. Standing to Pursue Injunctive Relief
Plaintiff asserts claims: (1) under the Consumer Product Safety Act, 15 U.S.C. § 2073, (2) for unjust enrichment, (3) for alleged violations of various state consumer protection laws, and (4) for breach of implied warranties under various state laws. (Compl. ¶¶ 86-175.) As a final remedy for the alleged violations of the Consumer Product Safety Act, Plaintiff seeks the same injunctive relief that fie seeks in the instant motion for a preliminary injunction. On his common law and state law claims, he seeks declaratory relief, money damages, and attorney’s fees on behalf of himself and a class of similarly-situated purchasers. Amazon does not dispute, at least at this juncture, that as a purchaser of the 1 Day Diet product, which allegedly contained undisclosed sibu-tramine, Plaintiff has standing to pursue appropriate money damages in connection with his purchases. However, Amazon contends that Plaintiff lacks standing to seek injunctive relief.
The jurisdiction of federal courts is limited, by Article III, Section 2 of the Constitution, “to the resolution of ‘cases’ and ‘controversies.’” Selevan v. N.Y. Thruway Auth.,
Although Plaintiffs motion is styled as a motion for preliminary injunctive relief— suggesting more litigation will follow — the injunction sought is the only relief obtainable from this Court, because Plaintiffs claims are bound for arbitration. Accordingly, the motion for a preliminary injunction represents the entire “case or controversy” before this Court.
“Each element of standing must be supported in the same way as any other matter on which the plaintiff bears the burden of proof, ie., with the manner and degree of evidence required at the successive stages of the litigation.” Lujan v. Defenders of Wildlife,
The “irreducible constitutional minimum” of standing requires a plaintiff to show that: (1) he has suffered a concrete and particularized injury-in-fact .which is actual or imminent, not “conjectural or hypothetical,” (2) the injury is fairly traceable to the defendant’s allegedly unlawful conduct, and (3) the injury will likely be redressed by the requested relief. Lujan,
“[W]hen seeking prospective injunctive relief, the plaintiff must prove the likelihood of future or continuing harm.” Pungitore v. Barbera,
In City of Los Angeles v. Lyons, the Supreme Court held that Lyons, who was placed in a chokehold by a police officer, did not have standing to seek a prospective preliminary injunction barring police officers from indiscriminately using choke-holds. The Court held that while Lyons had standing to sue for. compensatory damages, his past injury did not supply a predicate for prospective equitable relief because he did not face a real and immediate threat of future injury. Lyons,
Relying on Lyons, in Robidoux, the Second Circuit held that plaintiffs who were currently suffering as a result of the defendant’s conduct could seek a preliminary injunction because their alleged injury was “capable of being redressed through in-junctive relief at that moment,” however plaintiffs who were no longer suffering as a result of the defendant’s conduct no longer had standing to pursue prospective relief.
To the extent that Plaintiff seeks injunc-tive relief on behalf of a putative class of plaintiffs — either a class of Amazon customers who also purchased the 1 Day Diet product, or those who purchased or will purchase any other dietary supplements containing sibutramine — he lacks standing to pursue such relief for two reasons. First, he must personally have standing to secure prospective relief on behalf of a class, and for reasons already explained, he lacks such standing. Spiro,
Accordingly, Plaintiffs motion for in-junctive relief, whether on an individual basis or on a class basis, is denied for lack of standing.
C. Preliminary Statutory Injunction Pursuant to Consumer Product Safety Act
The CPSA provides that “[a]ny interested person ... may bring an action ... to enforce a consumer product safety rule ... and to obtain appropriate injunctive relief.” 15 U.S.C.A. § 2073(a).
Plaintiff asserts that “ ‘[w]hen an injunction is expressly, authorized by statute, the standard preliminary injunction test is not applied. Instead, the Court must look to the ‘statutory conditions for injunctive relief,’ and may issue a preliminary injunction if those conditions are met.’ ” Barkley v. United Homes, LLC,
The CPSA allows for private enforcement of “consumer product safety rule[s].” 15 U.S.C.A. § 2073(a). The term “consumer product safety rule” is defined to mean “a consumer products safety standard ... declaring a consumer product a banned hazardous product.” 15 U.S.C.A. § 2052(a)(6). A “consumer product,” in turn, is defined as “any article, or component part thereof, produced or distributed (i) for sale to a consumer for use in or around a permanent or temporary household or residence, a school, in recreation, or otherwise, or (ii) for the personal use, consumption or enjoyment of a consumer in or around a permanent or temporary household or residence, a school, in recreation, or otherwise.” 15 U.S.C.A. § 2052(a)(5). However, the statute expressly excludes, from the definition of “consumer product” both “drugs, devices, or cosmetics,” and “food,” as defined by, inter alia, subsections 201(f), (g), (h), and (i) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.A. § 321(f), (g), (h), and (i). 15 U.S.C.A. § 2052(a)(5)(H) and (I). Plaintiff contends that the 1 Day Diet product was not marketed as a drug containing sibutramine, but as a dietary supplement, and that the term “dietary supplement” is separately defined in subsection (ff) the Federal Food, Drug, and Cosmetic Act. 21 U.S.C.A. § 321(ff). Thus, Plaintiff contends that, as a dietary supplement, the ! Day Diet product is not exempt from the definition of “consumer product,” and is subject to regulation under the CPSA, including through a private enforcement action.
Plaintiff next alleges that the specific “consumer product safety rule” that Amazon violated by selling 1 Day Diet is contained in the Poison Prevention Packaging Act (“PPPA”), 16 C.F.R. § 1700.14, which requires special packaging child-proof for certain products, including “controlled drugs” and “prescription drugs” — which Plaintiff contends 1 Day Diet is, as a product containing sibutramine. 16 C.F.R. § 1700.14(a)(4) and (10). The PPPA does not apply to “dietary supplements” unless they contain “an equivalent of 250 mg or more of elemental iron,” which Plaintiff does not allege that 1 Day Diet contains. 16 C.F.R. § 1700.14(a)(13).
Plaintiff cannot have it both ways. Either 1 Day Diet is a “drug,” containing sibutramine, thus not a “consumer product” under the CPSA — in which case, Plaintiff may be correct that the PPPA requires special packaging, but Plaintiff has no private right of action to enforce the rule — or it is a “dietary supplement” under the CPSA — in which case it is not a drug under the PPSA and Plaintiff has cited no “consumer product safety rule” that he can enforce under the CPSA. Accordingly, because Plaintiff has failed to demonstrate that he is likely to prevail on
CONCLUSION
Amazon’s motion to dismiss is granted because all of Plaintiffs claims are subject to mandatory arbitration. Plaintiffs motion for a preliminary injunction is denied because (1) Plaintiff lacks standing to pursue a traditional preliminary injunction and cannot invoke the CPSA because it has no application in this case. The Clerk of Court is respectfully directed to close the case.
SO ORDERED.
Notes
. Plaintiff does not dispute that when he created his account in 2008, he affirmatively clicked a button expressly assenting to be bound to the terms of the 2008 Conditions of Use. In his opposition brief, he repeatedly faults Amazon for failing to produce a copy of his June 2008 online registration form. Amazon is under no obligation to produce Plaintiff's registration records, as Amazon does not allege that the 2008 Conditions of Use govern this dispute. In any event, Plaintiff's challenge “does not negate the uncontroverted and overwhelming evidence demonstrating that plaintiff could not have become a member of [Amazon].com without first agreeing to the website's [Conditions of Use], which included the forum selection clause” Zaltz v. JDATE,
. In this case, this may be a distinction without a difference, as this Court's reasoning would apply with equal force if Amazon’s motion were to be construed as a motion to compel, given that the facts are not in dispute and this Court finds that "all of the plaintiff’s claims must be submitted to arbitration,” and "no useful purpose [would] be served by granting a stay of these proceedings,” rather than dismissing the entire action.' See Berger v. Cantor Fitzgerald Sec.,
. Alternatively, the Court construes Amazon’s motion as a 'motion to dismiss the Complaint under Rule 12(b)(3) for improper venue, as it would in a case involving a binding forum selection clause. See Orlander v. Staples, Inc., No. 13 CIV. 703 NRB,
. "[W]hile doubts concerning the scope of an arbitration clause should be resolved in favor of arbitration, the presumption does not apply ■to disputes concerning whether an agreement to arbitrate has been made.” Applied Energetics, Inc. v. NewOak Capital Mkts., LLC,
. Spam Arrest, LLC v. Replacements, Ltd., No. C12-481RAJ,
. See Fteja,
. The Conditions of Use that Plaintiff contends apply in this case, the 2008 Conditions of Use, contain a mandatory forum selection clause which states, in relevant part, that “[a]ny dispute relating in any way to your visit to Amazon.com ... shall be adjudicated in any state or federal court in King County, Washington, and you consent to exclusive jurisdiction and venue in such courts." (Duncan Decl., Ex. C) (emphasis added). In its reply, Amazon does not raise the mandatory forum selection clause, but instead argues that the 2012 Conditions of Use (which do not contain a similar provision) are applicable in this case. Because the Court concludes that the 2012 Conditions of Use apply, the Court does not address the significance of the forum selection clause in the 2008 agreement.
. Plaintiff relies on In re Zappos.com, Inc. Customer Data Sec. Breach Litig.,
. See also McNair v. Synapse Grp. Inc.,
. Several courts have declined to follow Lyons in consumer protection cases. See, e.g., Delgado v. Ocwen Loan Servicing, LLC, No. 13-CV-4427 NGG RML,
. Even if Plaintiff had demonstrated an ongoing injury or sufficient risk of future injury, he would lack standing under the redressability prong of the traditional standing test because his alleged injury — purchasing the 1 Day Diet product unaware that it contained undisclosed sibutramine — would not be redressed by the sought injunction, which seeks to impose packaging requirements, enjoin future sales, and notify other past purchasers of dietary supplements. See Sprint Commc’ns Co. v. APCC Servs., Inc.,
. Whether Plaintiff can ultimately secure in-junctive relief under the CPSA is a merits question reserved for the arbitrator. The question here is whether this Court should grant preliminary injunctive relief under the CPSA prior to dismissing the matter in favor of arbitration.
